Cornerstone Planning Group LLC Bristol Myers Squibb CO Transaction History
Cornerstone Planning Group LLC
- $378 Billion
- Q3 2024
A detailed history of Cornerstone Planning Group LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cornerstone Planning Group LLC holds 655 shares of BMY stock, worth $35,835. This represents 0.01% of its overall portfolio holdings.
Number of Shares
655
Previous 609
7.55%
Holding current value
$35,835
Previous $29 Million
18.68%
% of portfolio
0.01%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding BMY
# of Institutions
2,468Shares Held
1.5BCall Options Held
29.6MPut Options Held
32.2M-
Vanguard Group Inc Valley Forge, PA187MShares$10.2 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.68 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$5 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.26 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$3.23 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $116B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...